Lotus Pharmaceuticals, Inc. 

(Public, OTC:LTUS)   Watch this stock   
Find more results for LTUS
Nov 12, 2009
Q3 2009 LOTUS PHARM INC Earnings Release
  

Key stats and ratios

Q3 (Sep '09) 2008
Net profit margin 37.15% 17.33%
Operating margin 41.43% 20.42%
EBITD margin - 21.28%
Return on average assets 28.23% 25.43%
Return on average equity 37.99% 35.64%
Employees 199 -

Address

16 Cheng Zhuang Road Feng Tai District
, BEJ 100071
China
+86-10-63899868 (Phone)
+86-10-63899867 (Fax)

Website links

Lotus Pharmaceuticals, Inc. discussions

  View all discussions »

Description

Lotus Pharmaceuticals, Inc. (Lotus) operates, controls and owns the pharmaceutical businesses in China of Beijing Liang Fang Pharmaceutical Co., Ltd. (Liang Fang) and Beijing En Zhe Jia Shi Pharmaceutical Co., Ltd. (En Zhe Jia), collectively Lotus East. Lotus provides business consulting and other general business operation services to Lotus East. Liang Fang is engaged in the production, trade and retailing of pharmaceuticals, focusing on the development of medicines. Liang Fang owns and operates 10 drug stores throughout Beijing, China that sell Western and traditional Chinese medications, lease medical treatment facilities to licensed physicians, and generate revenues from the leasing of retail space to third party vendors and the leasing of advertising locations at its retail stores. En Zhe Jia is a manufacturer for Liang Fang and maintains facilities for the production of medicines, Chinese medicine, as well as the research and production of other new medicines.

Officers and directors

Zhong Yi Liu
Chairman of the Board, President, Chief Executive Officer
Age: 48
Yan Zeng
Chief Financial Officer
Age: 41
Ian Ashley
Director
Age: 39
Ping Li
Director
Age: 47
Jin Liu
Director
Age: 72
Xuemei Xian
Director
Age: 39
Zhenghong Song
Director
Age: 42